AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,218 | -33.8% | 86,417 | -28.6% | 0.00% | – |
| Q2 2023 | $199,814 | +50.7% | 121,099 | +4.2% | 0.00% | – |
| Q1 2023 | $132,550 | +373.4% | 116,272 | +387.5% | 0.00% | – |
| Q3 2022 | $28,000 | -94.2% | 23,850 | -87.0% | 0.00% | – |
| Q1 2022 | $479,000 | -86.6% | 183,611 | -80.0% | 0.00% | – |
| Q4 2021 | $3,572,000 | +237.9% | 918,478 | +278.8% | 0.00% | – |
| Q3 2021 | $1,057,000 | +28.6% | 242,474 | +17.1% | 0.00% | – |
| Q2 2021 | $822,000 | -49.6% | 207,110 | -34.0% | 0.00% | – |
| Q1 2021 | $1,631,000 | +19.2% | 313,773 | +22.7% | 0.00% | – |
| Q4 2020 | $1,368,000 | +44.0% | 255,748 | +30.7% | 0.00% | – |
| Q3 2020 | $950,000 | -0.7% | 195,612 | -0.7% | 0.00% | – |
| Q2 2020 | $957,000 | +343.1% | 197,000 | +99.8% | 0.00% | – |
| Q1 2020 | $216,000 | +8.0% | 98,610 | +186.7% | 0.00% | – |
| Q4 2019 | $200,000 | – | 34,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |